Annual report [Section 13 and 15(d), not S-K Item 405]

SCHEDULE OF PREVIOUSLY REPORTED CONSOLIDATED FINANCIAL STATEMENTS (Details)

v3.25.1
SCHEDULE OF PREVIOUSLY REPORTED CONSOLIDATED FINANCIAL STATEMENTS (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Current Assets:      
Cash and cash equivalents $ 41,774 $ 98,721 $ 36,562
Marketable securities 13,630 22,970  
Total Current Assets 141,152 221,734  
Total Assets 217,988 428,519  
Cash Flows From Investing Activities:      
Proceeds from sale of marketable securities 10,500 16,442
Purchase of marketable securities (1,160) (39,412)
Net Cash Used In Investing Activities 4,148 (36,210) (57,441)
Net Increase In Cash and Cash Equivalents and Restricted Cash (56,948) 62,167 (138,243)
Cash and Cash Equivalents and Restricted Cash - Beginning of Year 98,800 36,633 174,876
Cash and Cash Equivalents and Restricted Cash - End of Year 41,852 98,800 36,633
Cash and cash equivalents and restricted cash consisted of the following:      
Cash and cash equivalents 41,774 98,721 36,562
Restricted cash 78 79 71
Previously Reported [Member]      
Current Assets:      
Cash and cash equivalents   121,691  
Marketable securities    
Total Current Assets   221,734  
Total Assets   428,519  
Cash Flows From Investing Activities:      
Proceeds from sale of marketable securities    
Purchase of marketable securities    
Net Cash Used In Investing Activities   (13,240)  
Net Increase In Cash and Cash Equivalents and Restricted Cash   85,137  
Cash and Cash Equivalents and Restricted Cash - Beginning of Year 121,770 36,633  
Cash and Cash Equivalents and Restricted Cash - End of Year   121,770 36,633
Cash and cash equivalents and restricted cash consisted of the following:      
Cash and cash equivalents   121,691  
Restricted cash   79  
Revision of Prior Period, Reclassification, Adjustment [Member]      
Current Assets:      
Cash and cash equivalents   (22,970)  
Marketable securities   22,970  
Total Current Assets    
Total Assets    
Cash Flows From Investing Activities:      
Proceeds from sale of marketable securities   16,442  
Purchase of marketable securities   (39,412)  
Net Cash Used In Investing Activities   (22,970)  
Net Increase In Cash and Cash Equivalents and Restricted Cash   (22,970)  
Cash and Cash Equivalents and Restricted Cash - Beginning of Year $ (22,970)  
Cash and Cash Equivalents and Restricted Cash - End of Year   (22,970)
Cash and cash equivalents and restricted cash consisted of the following:      
Cash and cash equivalents   (22,970)  
Restricted cash